Abstract
The increasing complexity of in vivo imaging technologies, coupled with the development of cell therapies, has fuelled a revolution in immune cell tracking in vivo. Powerful magnetic resonance imaging (MRI) methods are now being developed that use iron oxide- and 19F-based probes. These MRI technologies can be used for image-guided immune cell delivery and for the visualization of immune cell homing and engraftment, inflammation, cell physiology and gene expression. MRI-based cell tracking is now also being applied to evaluate therapeutics that modulate endogenous immune cell recruitment and to monitor emerging cellular immunotherapies. These recent uses show that MRI has the potential to be developed in many applications to follow the fate of immune cells in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bousso, P. & Moreau, H. D. Functional immunoimaging: the revolution continues. Nature Rev. Immunol. 12, 858–864 (2012).
Thakur, M. L., Lavender, J. P., Arnot, R. N., Silvester, D. J. & Segal, A. W. Indium-111-labeled autologous leukocytes in man. J. Nuclear Med. 18, 1014–1021 (1977).
Tjuvajev, J. G. et al. Imaging the expression of transfected genes in vivo. Cancer Res. 55, 6126–6132 (1995).
Koehne, G. et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nature Biotech. 21, 405–413 (2003).
Dubey, P. et al. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc. Natl Acad. Sci. USA 100, 1232–1237 (2003).
Yaghoubi, S. S. et al. Noninvasive detection of therapeutic cytolytic T cells with [18F]-FHBG PET in a patient with glioma. Nature Clin. Pract. Oncol. 6, 53–58 (2009).
Aoki, I. et al. Cell labeling for magnetic resonance imaging with the T-1 agent manganese chloride. NMR Biomed. 19, 50–59 (2006).
Hawrylak, N. et al. Nuclear-magnetic-resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp. Neurol. 121, 181–192 (1993).
Bulte, J. W. M. & Kraitchman, D. L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17, 484–499 (2004).
Gorelik, M. et al. Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor. Radiology 265, 175–185 (2012).
Cromer Berman, S. M. et al. Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis. Magn. Reson. Med. 69, 255–262 (2013).
Bulte, J. W. et al. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn. Reson. Med. 25, 148–157 (1992).
Bulte, J. W. et al. Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn. Reson. Med. 29, 32–37 (1993).
Yeh, T. C., Zhang, W., Ildstad, S. T. & Ho, C. Intracellular labeling of T-cells with superparamagnetic contrast agents. Magn. Reson. Med. 30, 617–625 (1993).
Frank, J. A. et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228, 480–487 (2003).
Arbab, A. S. et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 18, 553–559 (2005).
Thu, M. S. et al. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nature Med. 18, 463–467 (2012).
Ahrens, E. T., Feili-Hariri, M., Xu, H., Genove, G. & Morel, P. A. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn. Reson. Med. 49, 1006–1013 (2003).
Walczak, P. et al. Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent. Nanomedicine 2, 89–94 (2006).
Kircher, M. F. et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 63, 6838–6846 (2003).
Daldrup-Link, H. E. et al. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur. Radiol. 15, 4–13 (2005).
Moore, A. et al. MRI of insulitis in autoimmune diabetes. Magn. Reson. Med. 47, 751–758 (2002).
Anderson, S. A. et al. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann. Neurol. 55, 654–659 (2004).
Baumjohann, D. et al. In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. Eur. J. Immunol. 36, 2544–2555 (2006).
Rohani, R. et al. In vivo cellular MRI of dendritic cell migration using micrometer-sized iron oxide (MPIO) particles. Mol. Imaging Biol. 13, 679–694 (2011).
Long, C. M., van Laarhoven, H. W., Bulte, J. W. & Levitsky, H. I. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res. 69, 3180–3187 (2009).
Shapiro, E. M., Medford-Davis, L. N., Fahmy, T. M., Dunbar, C. E. & Koretsky, A. P. Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI. Contrast Media Mol. Imaging 2, 147–153 (2007).
Heyn, C. et al. In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn. Reson. Med. 55, 23–29 (2006).
Chan, T. W., Eley, C., Liberti, P., So, A. & Kressel, H. Y. Magnetic resonance imaging of abscesses using lipid-coated iron oxide particles. Investigative Radiol. 27, 443–449 (1992).
Dousset, V. et al. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am. J. Neuroradiol. 27, 1000–1005 (2006).
Vellinga, M. M. et al. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131, 800–807 (2008).
Sosnovik, D. E. & Nahrendorf, M. Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction. Circ. Cardiovasc. Imaging 5, 551–554 (2012).
Gaglia, J. L. et al. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J. Clin. Invest. 121, 442–445 (2011).
Luciani, A. et al. Adipose tissue macrophages: MR tracking to monitor obesity-associated inflammation. Radiology 263, 786–793 (2012).
Kanno, S. et al. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 104, 934–938 (2001).
Harisinghani, M. G. et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New Engl. J. Med. 348, 2491–2499 (2003).
Kooi, M. E. et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107, 2453–2458 (2003).
Siglienti, I., Bendszus, M., Kleinschnitz, C. & Stoll, G. Cytokine profile of iron-laden macrophages: implications for cellular magnetic resonance imaging. J. Neuroimmunol. 173, 166–173 (2006).
Verdijk, P. et al. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int. J. Cancer 120, 978–984 (2007).
de Vries, I. J. M. et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nature Biotech. 23, 1407–1413 (2005).
Weissleder, R. et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am. J. Roentgenol. 152, 167–173 (1989).
Riess, J. G. Oxygen carriers (“blood substitutes”) — raison d'etre, chemistry, and some physiology. Chem. Rev. 101, 2797–2919 (2001).
Janjic, J. M. & Ahrens, E. T. Fluorine-containing nanoemulsions for MRI cell tracking. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol 1, 492–501 (2009).
Holland, G. N., Bottomley, P. A. & Hinshaw, W. S. F-19 magnetic-resonance imaging. J. Magn. Reson. 28, 133–136 (1977).
Ahrens, E. T., Flores, R., Xu, H. Y. & Morel, P. A. In vivo imaging platform for tracking immunotherapeutic cells. Nature Biotech. 23, 983–987 (2005).
Bulte, J. W. M. Hot spot MRI emerges from the background. Nature Biotech. 23, 945–946 (2005).
Janjic, J. M. Srinivas, M., Kadayakkara, D. K. & Ahrens, E. T. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. J. Am. Chem. Soc. 130, 2832–2841 (2008).
Srinivas, M. et al. In vivo cytometry of antigen-specific t cells using 19F MRI. Magn. Reson. Med. 62, 747–753 (2009).
Helfer, B. M. et al. Functional assessment of human dendritic cells labeled for in vivo F-19 magnetic resonance imaging cell tracking. Cytotherapy 12, 238–250 (2010).
Srinivas, M., Morel, P. A., Ernst, L. A., Laidlaw, D. H. & Ahrens, E. T. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn. Reson. Med. 58, 725–734 (2007).
Kadayakkara, D. K. et al. Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas 39, 510–515 (2010).
Ahrens, E. T., Young, W. B., Xu, H. & Pusateri, L. K. Rapid quantification of inflammation in tissue samples using perfluorocarbon emulsion and fluorine-19 nuclear magnetic resonance. Biotechniques 50, 229–234 (2011).
Kadayakkara, D. K., Ranganathan, S., Young, W. B. & Ahrens, E. T. Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI. Lab Invest. 92, 636–645 (2012).
Hertlein, T. et al. Visualization of abscess formation in a murine thigh infection model of Staphylococcus aureus by F-19-magnetic resonance imaging (MRI). PLoS ONE 6, e18246 (2011).
Hitchens, T. K. et al. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn. Reson. Med. 65, 1144–1153 (2011).
Flogel, U. et al. Noninvasive detection of graft rejection by in vivo19F MRI in the early stage. Am. J. Transplant. 11, 235–244 (2011).
Noth, U. et al. Perfluoro-15-crown-5-ether labelled macrophages in adoptive transfer experimental allergic encephalomyelitis. Artif. Cells Blood Substit. Immobil. Biotechnol. 25, 243–254 (1997).
Weise, G., Basse-Luesebrink, T. C., Wessig, C., Jakob, P. M. & Stoll, G. In vivo imaging of inflammation in the peripheral nervous system by 19F MRI. Exp. Neurol. 229, 494–501 (2011).
Ebner, B. et al. Early assessment of pulmonary inflammation by 19F MRI in vivo. Circ. Cardiovasc. Imag. 3, U202–U109 (2010).
Flogel, U. et al. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 118, 140–148 (2008).
O'Hanlon, C. E., Amede, K. G., O'Hear, M. R. & Janjic, J. M. NIR-labeled perfluoropolyether nanoemulsions for drug delivery and imaging. J. Fluor. Chem. 137, 27–33 (2012).
Morel, P. A. et al. Gene expression analysis of dendritic cells that prevent diabetes in NOD mice: analysis of chemokines and costimulatory molecules. J. Leukoc. Biol. 90, 539–550 (2011).
Tannous, B. A. et al. Metabolic biotinylation of cell surface receptors for in vivo imaging. Nature Methods 3, 391–396 (2006).
Weissleder, R. et al. In vivo magnetic resonance imaging of transgene expression. Nature Med. 6, 351–355 (2000).
Bar-Shir, A. et al. Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expression. J. Am. Chem. Soc. 135, 1617–1624 (2013).
Ahrens, E. T. Contrast agents for magnetic resonance imaging and methods related thereto. US Patent 10/384,496 (2003).
Genove, G., DeMarco, U., Xu, H. Y., Goins, W. F. & Ahrens, E. T. A new transgene reporter for in vivo magnetic resonance imaging. Nature Med. 11, 450–454 (2005).
Cohen, B., Dafni, H., Meir, G., Harmelin, A. & Neeman, M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7, 109–117 (2005).
Iordanova, B. & Ahrens, E. T. In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration. Neuroimage 59, 1004–1012 (2012).
Gilad, A. A. et al. Artificial reporter gene providing MRI contrast based on proton exchange. Nature Biotech. 25, 217–219 (2007).
Sherry, A. D. & Woods, M. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu. Rev. Biomed. Eng. 10, 391–411 (2008).
Chan, K. W. et al. MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nature Mater. 12, 268–275 (2013).
Airan, R. D. et al. MRI biosensor for protein kinase A encoded by a single synthetic gene. Magn. Reson. Med. 68, 1919–1923 (2012).
Kadayakkara, D. K., Janjic, J. M., Pusateri, L. K., Young, W. B. & Ahrens, E. T. In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn. Reson. Med. 64, 1252–1259 (2010).
Sotak, C. H. et al. A new perfluorocarbon for use in fluorine-19 magnetic resonance imaging and spectroscopy. Magn. Reson. Med. 29, 188–195 (1993).
Zhong, J., Sakaki, M., Okada, H. & Ahrens, E. T. In vivo intracellular oxygen dynamics in murine brain glioma and immunotherapeutic response of cytotoxic T cells observed by fluorine-19 magnetic resonance imaging. PLoS One 8, e59479 (2013).
Partlow, K. C. et al. F-19 magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J. 21, 1647–1654 (2007).
Gilad, A. A. et al. Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles. Magn. Reson. Med. 61, 970–974 (2009).
Liu, G. et al. In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes. Magn. Reson. Med. 67, 1106–1113 (2012).
Bulte, J. W. In vivo MRI cell tracking: clinical studies. AJR Am. J. Roentgenol. 193, 314–325 (2009).
Richards, J. M. J. et al. Clinical cell tracking of mononuclear cells using magnetic resonance imaging and superparamagnetic particles of iron oxide. Br. J. Surg. 98, 4–4 (2011).
Keupp, J. et al. Simultaneous dual-nuclei imaging for motion corrected detection and quantification of 19F imaging agents. Magn. Reson. Med. 66, 1116–1122 (2011).
Aarntzen, E. H. et al. In vivo tracking techniques for cellular regeneration, replacement, and redirection. J. Nucl. Med. 53, 1825–1828 (2012).
Bulte, J. W. et al. MPI cell tracking: what can we learn from MRI? Proc. Soc. Photo-Opt. Instrum. Eng. 7965, 79650z (2011).
Acknowledgements
The authors are supported by US National Institutes of Health grants R01-CA134633, P41-EB0019772, R01-NS045062, R01-EB007825, R01-DA026299 and U54-CA151838, the Maryland Stem Cell Research Foundation and the California Institute for Regenerative Medicine.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
E.T.A. is a stockholder and board member of Celsense, Inc., Pittsburgh, Pennsylvania, USA.
Rights and permissions
About this article
Cite this article
Ahrens, E., Bulte, J. Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol 13, 755–763 (2013). https://doi.org/10.1038/nri3531
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri3531
This article is cited by
-
MRI-Based Cell Tracking of OATP-Expressing Cell Transplants by Pre-Labeling with Gd-EOB-DTPA
Molecular Imaging and Biology (2024)
-
Activatable near-infrared probes for the detection of specific populations of tumour-infiltrating leukocytes in vivo and in urine
Nature Biomedical Engineering (2023)
-
Nanomaterial-based contrast agents
Nature Reviews Methods Primers (2023)
-
Advances in NK cell therapy for brain tumors
npj Precision Oncology (2023)
-
One-pot synthesis of iron core—iron oxide shell nanoparticles with potential for magnetic imaging
Journal of Nanoparticle Research (2023)